Oxelumab is a human monoclonal antibody designed for the treatment of asthma.

[1] Oxelumab was developed by Genentech and co-developed by Roche.

Immune activation: Dostarlimab Other: Ibalizumab This monoclonal antibody–related article is a stub.

You can help Wikipedia by expanding it.This antineoplastic or immunomodulatory drug article is a stub.

You can help Wikipedia by expanding it.